Events
Pharmaceutical and Biotech Leaders' Summit, 16-18 January 2007, Delray Beach, Florida, USA
Moving the needle: an integrative approach to the R&D productivity conundrum
As we all know too well, R&D productivity has been impacted by high late-stage attrition, accelerating costs, and historically low number of candidate compounds. While, over the years, the industry has embarked on many worthwhile initiatives, the downward trend has, by and large, proved itself resistant to these efforts. However, due to a confluence of factors, we now have the opportunity to make a dent in the trend line.
This presentation by Wade Speir of PA Consulting Group will suggest that the answer to the R&D productivity conundrum lies in a portfolio of simultaneous and closely related initiatives, which cumulatively will improve productivity. We will explore some of these initiatives and the linkages between them:
- conducting more experimental/translational (as opposed to regulatory) trials, off-shore, to rapidly and economically generate the information required to make superior decisions
- using predictive models (based on the value of information paradigm) to guide decisions about which experimental/translational trials to conduct and in which order (or maybe in parallel)
- implementing an operations infrastructure that will facilitate the conduct of a greater number of smaller and faster trials.
For further information please e-mail: healthcare@paconsulting.com
|
